Meeting
2019 ASCO Annual Meeting
A phase III, multicenter study to assess the diagnostic performance and clinical impact of 18F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer (CONDOR).
Authors
Michael J. Morris
Memorial Sloan Kettering Cancer Center, New York, NY
Michael J. Morris , Frederic Pouliot , Lawrence Saperstein , Steven P. Rowe , Michael A. Gorin , David Y. Josephson , Jeffrey Y.C. Wong , Peter Carroll , Tess Lin , Nancy Stambler , Vivien Wong , Jessica Donato Jensen , Barry A. Siegel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer - Advanced Disease
Clinical Trial Registration Number
NCT03739684
Citation
J Clin Oncol 37, 2019 (suppl; abstr TPS5093)
DOI
10.1200/JCO.2019.37.15_suppl.TPS5093
Abstract #
TPS5093
Poster Bd #
201b
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Diagnostic performance of Gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging in early-relapsed prostate cancer: Phase 3, prospective, multicenter study (IAEA-PSMA study).
First Author: Juliano J Cerci
Poster
2019 Genitourinary Cancers Symposium
Identification of bone involvement in patients with prostate cancer recurrence using 18F-fluciclovine PET/CT and impact on subsequent management.
First Author: Michael S Kipper
Poster
2024 ASCO Genitourinary Cancers Symposium
Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.
First Author: Ahmed M. Mahmoud
Poster
2023 ASCO Annual Meeting
PSMA PET guided salvage radiotherapy among patients with prostate cancer in the post-prostatectomy setting: A single center post-hoc analysis.
First Author: Clayton P Smith